Type 2 Diabetes Trial, Recruiting NCT05317585 Sponsor: University of Massachusetts, Worcester Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05317585
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 years or older
  • Women who are pregnant with a single baby and are 14 weeks pregnant or less at their first obstetric appointment
  • Women who have an established diagnosis of type 2 diabetes, confirmed by blood test results meeting specific thresholds (confirm with trial site for exact values)
  • Women who are receiving prenatal care at UMass Memorial Health Care and plan to give birth there
  • Women who are willing and able to give informed consent to participate

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Women who have been diagnosed with type 1 diabetes or gestational diabetes (diabetes that first develops during pregnancy)
  • Women who plan to receive prenatal care or give birth at a location other than UMass Memorial Health Care
  • Women who are unable to give informed consent to participate in the study
  • Women who are pregnant with more than one baby (such as twins or triplets)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gianna L Wilkie, MD, University of Massachusetts, Worcester

Phone: 7743642523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Massachusetts, Worcester
Registry
ClinicalTrials.gov
Start date
23 May 2024
Est. completion
1 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Large for Gestational Age Infant

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov